Resmed Inc
RMD- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000943819
In the last 90 days, Resmed Inc insiders filed 0 open-market purchases and 5 sales; 891 institutions reported holding it in 13F filings for Q2 2026, worth $19.4B in total; Giverny Capital is the only superinvestor holding it.
Other share classesRSMDF
Holders of 5% or more of RMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Resmed Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 8.21%12.0M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.41%7.89M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Resmed Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 20263:12 PM ET | Vanguard Portfolio Management LLC | 13G | 5.41%7.89M shares | New | Mar 31, 2026 | SEC |
| Apr 29, 202610:43 AM ET | Vanguard Capital Management LLC | 13G | 8.21%12.0M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202611:34 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −13.66 ppfrom 13.66%Below 5% | Mar 13, 2026 | SEC |
| Oct 30, 20253:49 PM ET | Vanguard Group Inc | 13G/A | 13.66%20.0M shares | – | Sep 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Resmed Inc shares.
No Form 144 notices for Resmed Inc are on file.